Quadrant Private Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,610
| Closed | -$2.4M | – | 236 |
|
|
2026
Q1 | $2.4M | Buy |
2,610
+103
| +4% | +$104K | 0.37% | 79 |
|
|
2025
Q4 | $2.69M | Buy |
2,507
+229
| +10% | +$219K | 0.44% | 66 |
|
|
2025
Q3 | $1.74M | Buy |
2,278
+9
| +0.4% | +$6.7K | 0.32% | 82 |
|
|
2025
Q2 | $1.77M | Buy |
2,269
+152
| +7% | +$118K | 0.37% | 74 |
|
|
2025
Q1 | $1.75M | Sell |
2,117
-98
| -4% | -$81.5K | 0.44% | 68 |
|
|
2024
Q4 | $1.71M | Sell |
2,215
-244
| -10% | -$202K | 0.42% | 64 |
|
|
2024
Q3 | $2.18M | Buy |
2,459
+32
| +1% | +$28.8K | 0.54% | 57 |
|
|
2024
Q2 | $2.2M | Buy |
2,427
+46
| +2% | +$36.8K | 0.5% | 57 |
|
|
2024
Q1 | $1.85M | Buy |
2,381
+31
| +1% | +$22.1K | 0.47% | 61 |
|
|
2023
Q4 | $1.37M | Sell |
2,350
-36
| -2% | -$21K | 0.38% | 69 |
|
|
2023
Q3 | $1.28M | Sell |
2,386
-109
| -4% | -$56.2K | 0.43% | 62 |
|
|
2023
Q2 | $1.17M | Buy |
2,495
+39
| +2% | +$16.4K | 0.34% | 74 |
|
|
2023
Q1 | $844K | Buy |
2,456
+15
| +0.6% | +$5.06K | 0.26% | 90 |
|
|
2022
Q4 | $893K | Buy |
+2,441
| New | +$865K | 0.3% | 85 |
|
|
2022
Q2 | $767K | Buy |
2,366
+2
| +0.1% | +$600 | 0.31% | 73 |
|
|
2022
Q1 | $677K | Sell |
2,364
-2
| -0.1% | -$515 | 0.25% | 88 |
|
|
2021
Q4 | $654K | Buy |
2,366
+10
| +0.4% | +$2.54K | 0.24% | 90 |
|
|
2021
Q3 | $544K | Buy |
2,356
+22
| +0.9% | +$5.43K | 0.22% | 97 |
|
|
2021
Q2 | $536K | Sell |
2,334
-5
| -0.2% | -$1K | 0.22% | 99 |
|
|
2021
Q1 | $437K | Sell |
2,339
-194
| -8% | -$37.9K | 0.19% | 114 |
|
|
2020
Q4 | $428K | Sell |
2,533
-523
| -17% | -$78.1K | 0.19% | 110 |
|
|
2020
Q3 | $452K | Buy |
3,056
+10
| +0.3% | +$1.55K | 0.23% | 94 |
|
|
2020
Q2 | $500K | Buy |
3,046
+541
| +22% | +$83K | 0.29% | 79 |
|
|
2020
Q1 | $348K | Buy |
2,505
+550
| +28% | +$75.6K | 0.29% | 81 |
|
|
2019
Q4 | $257K | Hold |
1,955
| – | – | 0.23% | 91 |
|
|
2019
Q3 | $219K | Buy |
1,955
+1
| +0.1% | +$111 | 0.2% | 99 |
|
|
2019
Q2 | $217K | Hold |
1,954
| – | – | 0.2% | 96 |
|
|
2019
Q1 | $254K | Sell |
1,954
-5
| -0.3% | -$608 | 0.23% | 88 |
|
|
2018
Q4 | $227K | Hold |
1,959
| – | – | 0.24% | 83 |
|
|
2018
Q3 | $210K | Buy |
+1,959
| New | +$196K | 0.18% | 91 |
|
Other funds holding LLY
Quadrant Private Wealth Management's LLY Position: Q2 2026 in Review
Quadrant Private Wealth Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 2,610 shares — an estimated $2.4M sold.
Quadrant Private Wealth Management first reported a position in LLY in Q3 2018 and held it in 30 quarters. The position peaked at $2.69M in Q4 2025. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Quadrant Private Wealth Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
- Quadrant Private Wealth Management sold 2,610 Eli Lilly shares in Q2 2026, an estimated $2.4M.
- Quadrant Private Wealth Management first reported a position in Eli Lilly in Q3 2018 and held it in 30 quarters.
- Quadrant Private Wealth Management's Eli Lilly position peaked at $2.69M in Q4 2025.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Quadrant Private Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.